Gt Biopharma logo

Gt Biopharma Share Price Today

(NASDAQ: GTBP)

Gt Biopharma share price is $2.2 & ₹191.61 as on 5 Feb 2025, 2.30 'hrs' IST

$2.2

-0.05

(-2.22%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Gt Biopharma share price in Dollar and Rupees. Guide to invest in Gt Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Gt Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Gt Biopharma share price movements

  • Today's Low: $2.10
    Today's High: $2.31

    Day's Volatility :9.09%

  • 52 Weeks Low: $1.72
    52 Weeks High: $10.66

    52 Weeks Volatility :83.86%

Gt Biopharma (GTBP) Returns

PeriodGt Biopharma IncSector (Health Care)Index (Russel 2000)
3 Months
-26.42%
-0.5%
0.0%
6 Months
-2.22%
0.1%
0.0%
1 Year
-54.92%
3.2%
0.0%
3 Years
-97.19%
11.1%
-11.7%

Gt Biopharma (GTBP) Key Statistics

in dollars & INR

Previous Close
$2.25
Open
$2.1
Today's High
$2.31
Today's Low
$2.1
Market Capitalization
$6.2M
Today's Volume
$25.4K
52 Week High
$10.6599
52 Week Low
$1.72
Revenue TTM
$0.0
EBITDA
$-6.8M
Earnings Per Share (EPS)
$-7.39
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-131.48%

How to invest in Gt Biopharma Stock (GTBP) from India?

It is very easy for Indian residents to invest directly in Gt Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gt Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gt Biopharma or GTBP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gt Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gt Biopharma shares which would translate to 0.396 fractional shares of Gt Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gt Biopharma, in just a few clicks!

Returns in Gt Biopharma (GTBP) for Indian investors in Rupees

The Gt Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gt Biopharma investment value today

Current value as on today

₹49,985

Returns

₹50,015

(-50.01%)

Returns from Gt Biopharma Stock

₹54,918 (-54.92%)

Dollar Returns

₹4,903 (+4.9%)

Indian investors sentiment towards Gt Biopharma (GTBP)

-54%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Gt Biopharma Stock from India on INDmoney has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Gt Biopharma

  • DekaBank Deutsche Girozentrale

    51.69%

  • BMO Capital Markets Corp.

    1.34%

  • Bank of Montreal

    1.34%

  • Geode Capital Management, LLC

    0.67%

  • Vanguard Group Inc

    0.47%

  • Susquehanna International Group, LLP

    0.45%

Analyst Recommendation on Gt Biopharma

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Gt Biopharma(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Gt Biopharma Stock (GTBP)

What analysts predicted

Upside of 400.0%

Target:

$11.00

Current:

$2.20

Insights on Gt Biopharma Stock (Ticker Symbol: GTBP)

  • Price Movement

    In the last 1 month, GTBP stock has moved down by -26.7%
  • GTBP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 113.6%
  • GTBP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 86.4% return, outperforming this stock by 183.6%

Gt Biopharma Technicals Summary

Sell

Neutral

Buy

Gt Biopharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Gt Biopharma (GTBP) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gt Biopharma Inc logo
-26.42%
-2.22%
-54.92%
-97.19%
2067.49%
Biontech Se logo
-2.55%
47.81%
22.02%
-32.21%
279.34%
Regeneron Pharmaceuticals, Inc. logo
-2.68%
-34.72%
-25.67%
12.0%
82.54%
Vertex Pharmaceuticals Incorporated logo
19.82%
3.52%
15.9%
98.26%
100.9%
Alnylam Pharmaceuticals, Inc. logo
16.23%
4.16%
57.39%
82.31%
115.97%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gt Biopharma Inc logo
NA
NA
NA
0.0
-1.31
-0.61
NA
5.41
Biontech Se logo
160.8
NA
0.04
-3.37
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.49
16.49
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gt Biopharma Inc logo
Buy
$6.2M
2067.49%
NA
0.0%
Biontech Se logo
Buy
$28.7B
279.34%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.3B
82.54%
16.49
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$121.1B
100.9%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.4B
115.97%
NA
-15.86%

About Gt Biopharma

GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias; and GTB-5550 that is in preclinical studies for treating patients with B7-H3 positive solid tumors. GT Biopharma, Inc. has a co-development partnership agreement with Altor BioScience Corporation for the clinical development of a 161533 (GTB-3550) TriKE fusion protein for cancer therapies; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in Brisbane, California.
Organization
Gt Biopharma
Employees
2
CEO
Mr. Michael Martin Breen
Industry
Pharmaceuticals: Other

Management People of Gt Biopharma

NameTitle
Mr. Michael Martin Breen
Interim CEO & Executive Chairman
Mr. Alan Louis Urban CPA
CFO & Secretary

Important FAQs about investing in GTBP Stock from India :

What is Gt Biopharma share price today?

Gt Biopharma share price today stands at $2.20, Open: $2.10 ; Previous Close: $2.25 ; High: $2.31 ; Low: $2.10 ; 52 Week High: $10.66 ; 52 Week Low: $1.72.

The stock opens at $2.10, after a previous close of $2.25. The stock reached a daily high of $2.31 and a low of $2.10, with a 52-week high of $10.66 and a 52-week low of $1.72.

Can Indians buy Gt Biopharma shares?

Yes, Indians can invest in the Gt Biopharma (GTBP) from India.

With INDmoney, you can buy Gt Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Gt Biopharma at zero transaction cost.

How can I buy Gt Biopharma shares from India?

It is very easy to buy Gt Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gt Biopharma (GTBP) be purchased?

Yes, you can buy fractional shares of Gt Biopharma with INDmoney app.

What are the documents required to start investing in Gt Biopharma stocks?

To start investing in Gt Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Gt Biopharma Stock (GTBP)?

Today’s highest price of Gt Biopharma (GTBP) is $2.31.

Today’s lowest price of Gt Biopharma (GTBP) is $2.10.

What is today's market capitalisation of Gt Biopharma?

Today's market capitalisation of Gt Biopharma GTBP is 6.2M

What is the 52 Week High and Low Range of Gt Biopharma Stock (GTBP)?

  • 52 Week High

    $10.66

  • 52 Week Low

    $1.72

What are the historical returns of Gt Biopharma (GTBP)?

  • 1 Month Returns

    -26.42%

  • 3 Months Returns

    -2.22%

  • 1 Year Returns

    -54.92%

  • 5 Years Returns

    2067.49%

Who is the Chief Executive Officer (CEO) of Gt Biopharma ?

Mr. Michael Martin Breen is the current Chief Executive Officer (CEO) of Gt Biopharma.